• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

Pulmonary Fibrosis News

FDA Puts FibroGen’s Pamrevlumab on Fast Track as IPF Treatment

September 14, 2018
GenomeWeb

Bristol-Myers Squibb to Use Natera’s Cell-Free DNA Assay in Immunotherapy Study

September 14, 2018
GenomeWeb

Gene Editing Company Inscripta Acquires Solana Biosciences

September 5, 2018
San Francisco Business Times

Months before drug launch, this Peninsula company drew people to get its sweat stopper

September 4, 2018
CNBC

SoftBank-backed 10x Genomics makes a clever buy to help unlock the human biological code

August 28, 2018
Puget Sound Business Journal

Seattle’s next big biotech, Adaptive Biotechnologies, seeks more space in Lake Union area

August 22, 2018
Mass Device

FDA approves Ivantis’ Hydrus microstent

August 13, 2018
Triangle Business Journal

Sage Therapeutics targets Triangle for national postpartum depression support center

August 13, 2018
Forbes

RegenXBio Gene Therapy Shows Early Promise For Eye Disease; Cholesterol Treatment Results Mixed

August 8, 2018
GenomeWeb

Natera Q2 Revenues Climb 21 Percent

August 1, 2018
Page 14 of 25« First«...1213141516...20...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close